Sotyktu 6 mg

SOTYKTU 6 MG tablets contain deucravacitinib, a medication used to manage moderate to severe plaque psoriasis. This oral treatment is designed to help reduce inflammation and improve skin condition.

SOTYKTU 6 MG tablets are primarily used for the treatment of moderate to severe plaque psoriasis in adults. Plaque psoriasis is a chronic skin condition characterized by red, itchy, and scaly patches. Deucravacitinib works by targeting specific pathways in the immune system to reduce inflammation and improve skin appearance. Patients often wonder, 'What is SOTYKTU used for?' This medication is specifically formulated to address the symptoms associated with plaque psoriasis.

Common effects of SOTYKTU 6 MG tablets may include nausea, diarrhea, and upper respiratory tract infections. Some users might experience headaches or fatigue. These effects can vary from person to person and are not experienced by everyone who takes the medication.

SOTYKTU 6 MG tablets should be handled with care. It is important to follow the advice of a healthcare provider regarding the use of this medication. Patients with a history of infections or immune system disorders should discuss their medical history with their healthcare provider before starting treatment. Always store the medication as directed to maintain its effectiveness.

SOTYKTU 6 MG tablets may interact with certain medications, including those that affect the immune system. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol consumption should be discussed with a healthcare provider, as it may affect the overall treatment plan.